INSTRUCTOR BIOS FALL 2021 - PHARMA CHALLENGES & OPPORTUNITIES CERTIFICATE
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
PHARMA CHALLENGES & OPPORTUNITIES CERTIFICATE FALL 2021 INSTRUCTOR BIOS
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Jordan
Berman
Jordan Berman is Vice-President,
Global Corporate Affairs, Business
Transformation and Strategic
Planning at Apotex. In this role, he
is responsible for developing and
communicating the organization’s narrative to a wide variety
of stakeholders. His broad focus is to protect and strengthen
the Apotex reputation, drive employee engagement and build
alignment with the company strategy. Jordan is also accountable
for the short and long term strategic planning for Apotex, as
well as enterprise strategic initiatives focused on transforming
the company’s operations.
Prior to Apotex, Jordan held dual corporate communications
and strategy roles for 10 years. This included a Global
Communications Leadership role supporting the Executive
Chairman for Johnson & Johnson’s medical devices business, a
$25 billion organization with 55,000 employees worldwide, as
well as many years at AstraZeneca Canada as head of Business
Planning & Risk Management.
Jordan holds a joint Master of Business Administration from
the Kellogg School of Management and the Schulich School
of Business and is a frequent speaker on a range of topics. He
is the author of the forthcoming book, The Trust Trifecta: A
Leader’s Guide to Gaining Trust.
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Ajay
Bhatia
Ajay Bhatia is a Commercial Leader
with over 17 years of experience
in the Canadian Pharmaceutical
Industry. Ajay started his career at
Johnson & Johnson in 2003 as a sales
representative and quickly progressed into roles of increasing
responsibility. In 2009 Ajay joined GSK in their Leadership
Development Program where he held various positions in the
Commercial Division including Market Access, Marketing and
Sales Management where he led a team of 8 individuals in the
GTA.
In 2018 Ajay joined Astellas where he has led the successful
launch of a new Oncology Franchise at the company. Ajay has
experience in various therapeutic areas including Primary Care,
Vaccines, Dermatology, Biologics and Oncology. He has won
a number of Canadian and Global Industry awards and enjoys
speaking at major Industry conferences.
Ajay holds an Hon. BSc from the University of Toronto and an
MBA in Strategic Marketing from McMaster University.
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Rafael
Chiuzi
Dr. Rafael Chiuzi is an experienced
Organizational Behaviour Consultant
with a strong, demonstrated capacity
to leverage human capital for the
benefit of organizations and people
alike. In his ten plus years of innovative practice in North
& South America, Europe and the Middle East, he has been
able to overcome widespread organizational challenges, and
successfully implement lasting and meaningful change.
Rafael is also a published author and Assistant Professor,
Teaching Stream, at the University of Toronto Mississauga
where he teaches organizational behaviour and related courses.
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Dorothy
Czylyski
Dorothy Czylyski has been working
in healthcare & pharmaceutical
marketing for 20 years.
With a Master of Science (MSc)
in Clinical Pharmacology, she started her marketing
communications career as a Medical Writer, moving into
Account Management and Operations at healthcare agencies
Medicus LifeBrands, SCRIPT, Klick Health, and most recently
Fresh Squeezed Ideas, an Insights & Strategy firm where she
was President.
In January 2019 Dorothy opened NFA Health in collaboration
with No Fixed Address Inc., a fully integrated marketing
agency. Dorothy has built an impressive portfolio over the
course of her career, working with pharma clients across almost
every therapeutic area, from insight & strategy development,
regulatory expertise, sales rep materials, and Advisory Board
meetings, to digital communications and media. Dorothy
sits on the Board of Directors for the Ontario Pharmaceutical
Marketing Association (OPMA) and is on multiple Advisory
Committees at the Pharmaceutical Advertising Advisory Board
(PAAB).
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Colin
Hall
Dr. Colin Hall holds a Ph.D. in
Enzymology / Biotechnology from
McGill University. His areas of
academic interest involved the
purification, stabilization and
characterization of enzymes.
He began his professional career as a Lead Scientist and
R & D Manager, tasked with the development of immuno-
chromatographic assays for infectious diseases and human
hormones. He has obtained Lead Auditor accreditations in ISO
13485 (medical devices), ISO 17025 (testing and calibration
labs) and ISO 9001 (quality management).
In his current role of Director of Quality Assurance and Regulatory
Affairs at Prollenium Medical Technologies, he coordinates the
audit program and performs licensing activities, working with
various agencies including Health Canada, FDA, European
Notified Bodies, ANVISA and the TGA.
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Jason
Field
Dr. Jason Field is President & CEO
of Life Sciences Ontario (LSO), the
industry voice for the life sciences
sector in Ontario. LSO is a member-
driven organization that represents and
promotes the province’s vibrant and diverse life sciences sector.
Jason obtained his PhD in Chemistry from the University
of Massachusetts and his undergraduate degree from the
University of Waterloo. Following graduate school, Jason
returned to Ontario and worked in the pharmaceutical industry
as a research scientist developing scalable manufacturing
processes of active pharmaceutical ingredients. In 2007, he
joined the Ministry of Economic Development and Trade (MEDT)
where he led a team of senior advisors dedicated to growing
Ontario’s life sciences and information and communication
technologies (ICT) sectors.
Jason sits on several boards and committees including UofT’s
faculty of medicine’s Translational Research Program, ReMAP,
Research Canada’s policy engagement committee and most
recently, BioTalent Canada. Jason is also the 2017 recipient of
the Distinguished Alumni Award from the University of Waterloo.
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Patricia
Gauthier
Patricia joined Moderna at the end
of 2020 as General Manager to set
up and lead Moderna’s Canadian
organization. Her responsibilities
included leading the delivery of
Moderna’s COVID-19 pandemic response and building a strong
pipeline of mRNA therapeutics and vaccines to create a solid
footprint for the innovative biotechnology company in Canada.
Patricia’s strength in building teams from the ground up has
helped her build a highly skilled team to drive Moderna’s
expansion in Canada.
Before joining Moderna, Patricia spent 12 years at GSK
holding senior roles including Head of Vaccines Business and
Head of Government Affairs and Market Access. With a drive
to produce results and turn challenges into opportunities,
Patricia successfully managed the creation of a public/private
partnership between NEOMED and GSK, managed P&L, and
led a corporate transformation initiative to embed a good
governance mindset and a drive for performance.
Patricia’s professional path has taken her around the world,
having lived in the US, Singapore and France, as well as
London while she was a lawyer at McCarthy Tetrault. She holds
an MBA from Montreal HEC and certifications in Strategic
Negotiation from Harvard Business School and Leadership in
Context from IMD.
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Duncan
Jones
Duncan holds a Bachelor’s
of Science (Chemistry and
Biochemistry), a Master’s of Science
(Biochemistry) and a Master’s of
Business Administration all from the
University of Toronto. In addition, he is a Project Management
Professional (PMP). For over 30 years, he has primarily worked
with inventors in the Life Sciences, especially University
professors assisting them in bringing their ideas to market.
He has worked in a major pharmaceutical company, as a
venture capitalist and with the technology transfer teams at
each of Ontario’s Universities. He has lectured on and taught
business and biotechnology at the high school, college and
university levels. Duncan also manages Hexagon Innovating, a
consulting firm focused on the fuzzy front end of new product
development, sourcing and in-licensing technology, performing
technology and intellectual property reviews, doing market
research and competitive intelligence, developing business
models and strategy, partnering, fundraising, as well as project
and portfolio management.
Duncan bringing his commercial and industry experience to
the classroom as well as his interest in pedagogy, especially as
it relates to critical thinking and experiential learning. Over the
last 2+ years, he has taught courses at UofT, including in the
Master of Biotechology, and undergraduate courses for the IMI
Business Minor and Human Biology (St George).
PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Rav
Kumar
Dr. Rav Kumar is Managing Director
of the Centre for Medicinal Chemistry,
University of Toronto Mississauga
(UTM). He is also a strategic advisor
to several start-up companies in the
pharmaceutical and life sciences industries.
Rav recently served as Managing Director of Apotex operations
in India leading over 2,000 professionals in Pharmaceutical
R&D, Manufacturing, Quality, Regulatory Affairs & Commercial
Services. Dr. Kumar spent 25 years with GlaxoSmithKline in the
UK, France and Canada at vice-president level leading R&D,
Business Development and Commercial functions. He has
been involved with development of numerous medicines and
vaccines plus many successful business change initiatives. Dr.
Kumar is passionate about growing Canadian Life Sciences and
has been involved with many industry-academic-government
collaborations. He conceived the $150M spinout of GSK’s
vaccines R&D to create the Neomed Vaccines and Biologics
Centre of Excellence in Montreal. For these contributions and
numerous leadership roles on boards, non-profits and industry
association work, he was recognized with the 2014 Award for
Leadership in in Canadian Pharmaceutical Sciences.
Rav has a Pharmacy Degree and completed a PhD in Novel
Drug Delivery at University of Bath in the UK.PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Timothy
Lee
Dr. Timothy Lee has a Ph.D. in
Biochemical Engineering. He then
did a post-doctoral fellowship and
eventually become a senior scientist
at SANOFI where he was involved
in the optimization of biologics processes to improve product
yield.
His area of expertise include bacterial and mammalian cell
culture fermentation, primary protein recovery and column
chromatography. Dr. Lee has also worked as a biopharmaceutical
consultant for the NIH, DARPA and Department of Defense
(DoD) on government funded projects.
He then moved to Allergan, California where he served as
Director of Research and Development formulating Botox for
different medical indications such as Osteoarthritis, reticular
back pain and migraine.
He is currently the Director of R&D at Prollenium Medical
Technologies working on new Hyaluronic Acid formulations
and bead technologies to bring the dermal products to market.
He has also published several patents & well established peer-
reviewed journals and presented extensively globally over the
last several years, outlining the work performed in the industry.PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Ryan W.
Lock
Ryan W. Lock is Director, Federal
Affairs and Public Policy for GSK
Canada. Leading a team within
GSK’s Government Affairs and
Market Access department, Ryan is
responsible for developing GSK policy positions on market
access and implementing evidence-driven national advocacy
campaigns. Ryan is also responsible for GSK’s publicly-tendered
vaccines portfolio, which includes managing relationships with
the Public Health Agency of Canada and provincial public
health departments.
Ryan has extensive policy experience in both industry and
government. Before joining GSK in February 2016, Ryan
was a member of the Ontario Public Service for 16 years. His
varied roles at the Ministry of Research and Innovation, the
Ministry of Consumer and Business Services; and the Ministry
of Economic Development. He helped shape and inform
Ontario’s Bill 160 health transparency legislation. In addition
to this, Ryan led the development of policies, programs, and
marketing initiatives to help reinforce Ontario’s position as a
Top Five life sciences cluster internationally.
Ryan has a Master’s in Public Administration from the University
of Western Ontario, and a Bachelor of Arts (Hons.), Political
Science and French (minor) from Wilfrid Laurier University in
Waterloo, Ontario.PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Leigh
Revers
Dr. Leigh Revers has more than 15
years of experience working in the
life sciences sector, both in academia
and industry.
Trained as a chemist and molecular biologist in the Dyson
Perrins Laboratory, he came to Canada in 1996 as the
recipient of a Leverhulme Scholarship to work with Prof. Harry
Schachter on developmental enzymes involved in human
diseases at Toronto’s Hospital for Sick Children. His research
interests in complex carbohydrates as mediators of events
at the cell-surface led to his interest in cancer. He joined Dr
Jean Gariépy’s research team in 1999 to work on novel toxins
capable of exploiting cancer-related carbohydrate signals.
A long-held interest in entrepreneurship led in 2000 to his
becoming a co-founder of Molecular Templates Inc. (MTI), an
private biotech company focussed on the development of novel
toxin-based cancer therapeutics.
In May 2006, he was appointed Assistant Director with the
MBiotech Programme at the University of Toronto. In 2007,
Dr. Revers co-founded a consulting practice, AdamsRevers,
which provides specialist scientific and financial services to
SMEs in the life sciences. Dr. Revers holds Bachelor’s, Master’s
and Doctoral degrees in Physical Sciences from University of
Oxford.PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Amyn
Sayani
Dr. Amyn Sayani is currently the
Director, Medical Evidence at
AstraZeneca Canada, where he
is accountable for all real-world
evidence, outcomes research studies,
and externally sponsored research across multiple therapy
areas.
Amyn joined AstraZeneca in March 2021 after 20 years at
GlaxoSmithKline and the last two years at a medical cannabis
company as Vice President, R&D. Amyn has served in
various roles of increasing responsibility across the drug
development and commercialization continuum, including
product development, regulatory and medical affairs, health
economics and outcomes research, and real-world evidence,
and market access. In his most recent role at GSK, Amyn led
the development and implementation of GSK’s RWE strategy
through broad partnerships across public, private and academic
stakeholders. He has authored numerous publications and
patents and has led numerous projects to optimize patient
access to innovative medicines. Amyn is a pharmacist by
training, and has a PhD in Pharmaceutical Sciences (Rutgers
University), and a Masters of Science in Health Research
Methodology (McMaster University, Ontario).PHARMA CHALLENGES &
INSTRUCTORS
OPPORTUNITIES CERTIFICATE
Bruce
Seet
Dr. Bruce Seet is currently Director,
Medical Affairs at Sanofi Pasteur
where he’s worked since 2014.
Bruce started his career in industry
at GlaxoSmithKline (GSK) in 2006
where he worked in various functional areas including medical
affairs, marketing, policy, and reimbursement and covered a
diversity of therapeutic areas including vaccines, oncology, rare
diseases and hematology. Dr. Seet is also an Adjunct Professor
in the Dept. of Molecular Genetics at the University of Toronto.
Among his volunteer work, he serves on BIOTECanada’s
Vaccine Industry Committee and is a member of the Research
Management Committee as well as the HQP Development
Committee for BioCanRx, a network that advances promising
cancer immunotherapeutics in Canada. Bruce is also the
founder and President/CEO of the Science to Business Network
(S2BN). As a science communicator, Bruce is a frequent
speaker, panelist and event moderator and serves as the host
and executive producer of the S2BN Podcast.
Bruce earned a B.Sc (Honours Physiology) and a Ph.D.
(Microbiology and Immunology) from Western University
(London, Canada), followed by a postdoctoral research
fellowship at Mt. Sinai Hospital (Toronto). While at GSK, he
completed his MBA at the Rotman School of Management
(Toronto).You can also read
